Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pulmonary Hypertension, March 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 168 articles:
HTML format


 

Single Articles

  1. BERNARDO RJ, Lu D, Ramirez RL 3rd, Hedlin H, et al
    Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
    Ann Am Thorac Soc. 2022 Mar 3. doi: 10.1513/AnnalsATS.202109-1051.
    PubMed    
    Abstract available

  2. BREEN E, Yuan JX
    Targeting ATP-sensitive K(+) Channels to Treat Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2022 Mar 3. doi: 10.1165/rcmb.2021-0549.
    PubMed    


  3. SALGUERO MV, Chan K, Greeley SAW, Dyamenahalli U, et al
    Novel KDM6A Kabuki Syndrome Mutation With Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension Requiring ECMO.
    J Endocr Soc. 2022;6:bvac015.
    PubMed    
    Abstract available

  4. LIU SF, Yan Y
    Animal models of pulmonary hypertension due to left heart disease.
    Animal Model Exp Med. 2022 Feb 9. doi: 10.1002/ame2.12214.
    PubMed    
    Abstract available

  5. MATSUI T, Kikuchi N, Serizawa N, Hagiwara N, et al
    Systemic sclerosis complicated by chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty: a case report.
    Eur Heart J Case Rep. 2022;6:ytac080.
    PubMed    
    Abstract available

  6. CLEMENTS W, Venn G, McGiffin D, Moriarty HK, et al
    Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and massive hemoptysis: The rationale for bronchial artery embolization.
    Respir Med. 2022 Feb 24:106784. doi: 10.1016/j.rmed.2022.106784.
    PubMed    
    Abstract available

  7. WALSH LJ, Collins C, Ibrahim H, Kerins DM, et al
    Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.
    J Med Case Rep. 2022;16:99.
    PubMed    
    Abstract available

  8. WANG Q, Sun Y, Zhao Q, Wu W, et al
    Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism.
    Animal Model Exp Med. 2022;5:38-47.
    PubMed    
    Abstract available

  9. RUDENKO T, Kamyshova E, Vasilyeva M, Bobkova I, et al
    Pulmonary Hypertension in Non-dialysis Chronic Kidney Disease: Its Prevalence and Possible Risk Factors.
    Saudi J Kidney Dis Transpl. 2021;32:1184-1185.
    PubMed    


  10. WERNER F, Kojonazarov B, Gassner B, Abesser M, et al
    Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice.
    Basic Res Cardiol. 2022;117:7.
    PubMed    


  11. HOPE KD, Spinner JA
    Right-Sided Heart Failure and Cor Pulmonale in the Pediatric Patient.
    Pediatr Rev. 2022;43:188-190.
    PubMed    


  12. HUITEMA MP, Mathijssen H, Bakker ALM, Mager JJ, et al
    Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screening.
    Respir Med. 2022 Feb 20:106762. doi: 10.1016/j.rmed.2022.106762.
    PubMed    
    Abstract available

  13. DIAO W, Liu G, Shi C, Jiang Y, et al
    Evaluating the Effect of Circ-Sirt1 on the Expression of SIRT1 and Its Role in Pathology of Pulmonary Hypertension.
    Cell Transplant. 2022;31:9636897221081479.
    PubMed    
    Abstract available

  14. VERWERFT J, Verbrugge FH, Claessen G, Herbots L, et al
    Exercise Systolic Reserve and Exercise Pulmonary Hypertension Improve Diagnosis of Heart Failure With Preserved Ejection Fraction.
    Front Cardiovasc Med. 2022;9:814601.
    PubMed    
    Abstract available

  15. CARTA AF, Lichtblau M, Berlier C, Saxer S, et al
    The Impact of Breathing Hypoxic Gas and Oxygen on Pulmonary Hemodynamics in Patients With Pulmonary Hypertension.
    Front Med (Lausanne). 2022;9:791423.
    PubMed    
    Abstract available

  16. JIA Z, Yan H, Wang S, Wang L, et al
    Shufeiya Recipe Improves Monocrotaline-Induced Pulmonary Hypertension in Rats by Regulating SIRT3/FOXO3a and Its Downstream Signaling Pathways.
    Dis Markers. 2022;2022:3229888.
    PubMed    
    Abstract available

  17. TZOUMAS A, Peppas S, Sagris M, Papanastasiou CA, et al
    Advances in treatment of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2022;212:30-37.
    PubMed    
    Abstract available

  18. GOSCINIAK P, Larysz M, Sagan L, Larysz B, et al
    Effective Balloon Pulmonary Angioplasty in a Patient with Chronic Thromboembolic Complications after Ventriculoatrial Shunt for Hydrocephalus in von Hippel-Lindau Disease.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  19. AKASLAN D, Atas H, Aslanger E, Kanar BG, et al
    Change in pulmonary arterial compliance and pulmonary pulsatile stress after balloon pulmonary angioplasty.
    Anatol J Cardiol. 2022;26:43-48.
    PubMed    
    Abstract available

  20. FU Z, Zhang J
    Molecular hydrogen is a promising therapeutic agent for pulmonary disease.
    J Zhejiang Univ Sci B. 2022;23:102-122.
    PubMed    
    Abstract available

  21. STEFFES LC, Austin ED
    Upfront Combination Therapy: Growing the Case to Get Ahead of Pediatric Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2022;19:163-165.
    PubMed    


  22. DOI A, Gajera J, Niewodowski D, Gangahanumaiah S, et al
    Surgical management of giant pulmonary artery aneurysms in patients with severe pulmonary arterial hypertension.
    J Card Surg. 2022;37:1019-1025.
    PubMed    
    Abstract available

  23. WU Y, Pan B, Zhang Z, Li X, et al
    Caspase-4/11-Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension.
    Hypertension. 2022 Jan 5:HYPERTENSIONAHA12117868.
    PubMed    
    Abstract available

  24. WANG MT, Charng MJ, Chi PL, Cheng CC, et al
    Gene Mutation Annotation and Pedigree for Pulmonary Arterial Hypertension Patients in Han Chinese Patients.
    Glob Heart. 2021;16:70.
    PubMed    
    Abstract available

  25. ROSSI R, Coppi F, Monopoli DE, Sgura FA, et al
    Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors.
    Cardiol J. 2022;29:163-165.
    PubMed    


  26. CHEN Y, Li S, Xu Z, Zhang Y, et al
    Aerobic training-mediated DNA hypermethylation of Agtr1a and Mas1 genes ameliorate mesenteric arterial function in spontaneously hypertensive rats.
    Mol Biol Rep. 2021;48:8033-8044.
    PubMed    
    Abstract available

  27. EILERS LF, Kyle WB, Allen HD, Qureshi AM, et al
    Patent Ductus Arteriosus.
    Pediatr Rev. 2021;42:632-634.
    PubMed    


  28. SUNG SH, Yeh WY, Chiang CE, Huang CJ, et al
    The prognostic significance of the alterations of pulmonary hemodynamics in patients with pulmonary arterial hypertension: a meta-regression analysis of randomized controlled trials.
    Syst Rev. 2021;10:284.
    PubMed    
    Abstract available

  29. DUSIK M, Fingrova Z, Ambroz D, Jansa P, et al
    The Role of Pulmonary Artery Wedge Pressure on the Incidence of Atrial Fibrillation and Atrial Tachycardias in Patients With Isolated Pre-capillary Pulmonary Hypertension.
    Physiol Res. 2021;70:841-849.
    PubMed    
    Abstract available

  30. SU J, Simonsen U, Mellemkjaer S, Howard LS, et al
    Limited value of pulse wave analysis in assessing arterial wave reflection and stiffness in the pulmonary artery.
    Physiol Rep. 2021;9:e15024.
    PubMed    
    Abstract available

  31. DEWEIRDT J, Ducret T, Quignard JF, Freund-Michel V, et al
    Effects of FW2 Nanoparticles Toxicity in a New In Vitro Pulmonary Vascular Cells Model Mimicking Endothelial Dysfunction.
    Cardiovasc Toxicol. 2022;22:14-28.
    PubMed    
    Abstract available

  32. ZHANG Y, Tang J, Li N, Tao J, et al
    Prenatal hypoxia induced ETBR activation and abnormal ROS signalling in pulmonary artery cells of rat offspring.
    Reprod Toxicol. 2021;105:91-100.
    PubMed    
    Abstract available

  33. KHOURY J, Adir Y, Gayer T, Kompanietz D, et al
    Veno-venous extracorporeal membrane oxygenation in pulmonary arterial hypertension - Bridging to recovery.
    Respir Med Res. 2021;80:100848.
    PubMed    


  34. SARZYNSKA K, Swiatoniowska-Lonc N, Dudek K, Jonas K, et al
    Quality of life of patients with pulmonary arterial hypertension: a meta-analysis.
    Eur Rev Med Pharmacol Sci. 2021;25:4983-4998.
    PubMed    
    Abstract available

  35. ZHAO Q, Guo N, Chen J, Parks D, et al
    Comparative assessment of efficacy and safety of ambrisentan and bosentan in patients with pulmonary arterial hypertension: A meta-analysis.
    J Clin Pharm Ther. 2022;47:146-156.
    PubMed    
    Abstract available

  36. DOUWES JM, Zijlstra WMH, Rosenzweig EB, Ploegstra MJ, et al
    Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine.
    Ann Am Thorac Soc. 2022;19:227-237.
    PubMed    
    Abstract available

  37. SARANGARM P, Elwood K
    Transition from IV epoprostenol to oral treprostinil in a patient with group 1 pulmonary arterial hypertension.
    Am J Health Syst Pharm. 2021;78:2110-2115.
    PubMed    
    Abstract available

  38. YILMAZ ES, Uzun O
    Low-dose thrombolysis for submassive pulmonary embolism.
    J Investig Med. 2021;69:1439-1446.
    PubMed    
    Abstract available

  39. LYU DM, Goff RR, Chan KM
    The Lung Allocation Score and Its Relevance.
    Semin Respir Crit Care Med. 2021;42:346-356.
    PubMed    
    Abstract available

  40. ROMANIELLO A, Rubattu S, Vaiarello V, Gigante A, et al
    Circulating NT-proANP level is a predictor of mortality for systemic sclerosis: a retrospective study of an Italian cohort.
    Expert Rev Clin Immunol. 2021;17:661-666.
    PubMed    
    Abstract available

  41. ATEF H, Abdeen H
    Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension.
    Sleep Breath. 2021;25:1953-1960.
    PubMed    
    Abstract available

  42. DUNMORE BJ, Jones RJ, Toshner MR, Upton PD, et al
    Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus.
    Cardiovasc Res. 2021;117:2309-2325.
    PubMed    
    Abstract available

  43. KUSAKA K, Nakano K, Fukuyo S, Miyazaki Y, et al
    A Case of Mixed Connective Tissue Disease Complicated by Pulmonary Hypertension and Ascites After Addition of Pulmonary Vasodilators.
    Mod Rheumatol Case Rep. 2022 Mar 11. pii: 6547077. doi: 10.1093.
    PubMed    
    Abstract available

  44. MIZUNO T, Sasaki K, Suzuki S, Nagao I, et al
    Case Report: Tricuspid Annuloplasty for Right-Sided Congestive Heart Failure Secondary to Pulmonary Hypertension in a Dog.
    Front Vet Sci. 2022;9:843792.
    PubMed    
    Abstract available

  45. SANTOS-MARTINEZ LE
    [Pulmonary hypertension. Defining the structure and the departmental function based on risk].
    Rev Med Inst Mex Seguro Soc. 2021;60:59-66.
    PubMed    
    Abstract available

  46. MELZIG C, Do TD, Egenlauf B, Partovi S, et al
    Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease.
    Eur Radiol. 2022 Mar 10. pii: 10.1007/s00330-022-08663.
    PubMed    
    Abstract available

  47. RAWLINGS GH, Beail N, Armstrong I, Thompson AR, et al
    Self-help cognitive behavioural therapy for anxiety in pulmonary hypertension: pilot randomised controlled trial.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  48. GARCIA MVF, Souza R, Caruso P
    External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  49. CONDLIFFE R, Bauchmuller K, Southern J, Kiely DG, et al
    Reply: External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension.
    ERJ Open Res. 2022;8.
    PubMed    
    Abstract available

  50. TROFIMOV NA, Rodionov AL, Egorov DV, Surkova TV, et al
    Histological Justification for the Need of Radiofrequency Ablation of Pulmonary Arteries in Patients with High-Grade Secondary Pulmonary Hypertension.
    Sovrem Tekhnologii Med. 2021;13:56-62.
    PubMed    
    Abstract available

  51. LECHARTIER B, Chaouat A, Aubert JD, Schwitter J, et al
    Magnetic resonance imaging in pulmonary hypertension: an overview of current applications and future perspectives.
    Swiss Med Wkly. 2022;152:w30055.
    PubMed    
    Abstract available

  52. SLAWEK-SZMYT S, Araszkiewicz A, Grygier M, Zielinski D, et al
    Chronic thromboembolic pulmonary hypertension complicated by left main compression syndrome.
    Kardiol Pol. 2022 Mar 8. pii: VM/OJS/J/88903. doi: 10.33963/KP.a2022.0067.
    PubMed    


  53. CALVIER L, Herz J, Hansmann G
    Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension.
    JACC Basic Transl Sci. 2022;7:164-180.
    PubMed    
    Abstract available

  54. WANG J, Niu Y, Luo L, Lu Z, et al
    Decoding ceRNA regulatory network in the pulmonary artery of hypoxia-induced pulmonary hypertension (HPH) rat model.
    Cell Biosci. 2022;12:27.
    PubMed    
    Abstract available

  55. YOGESWARAN A, Kuhnert S, Gall H, Faber M, et al
    Relevance of Cor Pulmonale in COPD With and Without Pulmonary Hypertension: A Retrospective Cohort Study.
    Front Cardiovasc Med. 2022;9:826369.
    PubMed    
    Abstract available

  56. ZHANG Y, Li X, Luo Q, Zhao Q, et al
    Heart-Rate Recovery at 1 Min After Exercise Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    Front Cardiovasc Med. 2022;9:795420.
    PubMed    
    Abstract available

  57. MAI AS, Lim OZH, Ho YJ, Kong G, et al
    Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis.
    Front Med (Lausanne). 2022;9:765461.
    PubMed    
    Abstract available

  58. BENMESSAOUD FA, Bendagha N, Soufiani A, Konate L, et al
    [Percutaneous dilation of mitral stenosis in patients with severe pulmonary hypertension during pregnancy].
    Pan Afr Med J. 2021;40:265.
    PubMed    
    Abstract available

  59. FUNK-HILSDORF TC, Behrens F, Grune J, Simmons S, et al
    Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer.
    Front Physiol. 2022;13:819145.
    PubMed    
    Abstract available

  60. WANG Q, Tian J, Li X, Liu X, et al
    Upregulation of Endothelial DKK1 (Dickkopf 1) Promotes the Development of Pulmonary Hypertension Through the Sp1 (Specificity Protein 1)/SHMT2 (Serine Hydroxymethyltransferase 2) Pathway.
    Hypertension. 2022 Mar 7:HYPERTENSIONAHA12118672.
    PubMed    
    Abstract available

  61. KAWAI M, Zhang E, Kabwe JC, Okada A, et al
    Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension.
    BMC Pulm Med. 2022;22:78.
    PubMed    
    Abstract available

  62. SLIVNICK J, Zareba KM, Varghese J, Truong V, et al
    Prevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis.
    Open Heart. 2022;9.
    PubMed    
    Abstract available

  63. MOHRI T, Goda A, Takeuchi K, Kikuchi H, et al
    High prevalence of occult left ventricular diastolic dysfunction detected by exercise stress test in systemic sclerosis.
    Sci Rep. 2022;12:2423.
    PubMed    
    Abstract available

  64. KOLSTAD KD, Khatri A, Donato M, Chang SE, et al
    Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension.
    Arthritis Res Ther. 2022;24:39.
    PubMed    
    Abstract available

  65. DAI HL, Zhang WH, Guang XF
    A 49-Year-Old Woman With Progressive Dyspnea.
    JAMA Cardiol. 2022;7:e214920.
    PubMed    


  66. COSTAGUTA A, Gutierrez MG, Costaguta G, Reyes N, et al
    Long term remission of portopulmonary hypertension with liver transplantation in a patient with cirrhosis associated to autoimmune hepatitis.
    Arch Argent Pediatr. 2022;120:e17-e20.
    PubMed    
    Abstract available

  67. SHOJI H, Yoshida Y, Sanada TJ, Naito A, et al
    The Isoquinoline-Sulfonamide Compound H-1337 Attenuates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Rats.
    Cells. 2021;11.
    PubMed    
    Abstract available

  68. TORBIC H, Hohlfelder B, Krishnan S, Tonelli AR, et al
    A Review of Pulmonary Arterial Hypertension Treatment in Extracorporeal Membrane Oxygenation: A Case Series of Adult Patients.
    J Cardiovasc Pharmacol Ther. 2022;27:10742484211069005.
    PubMed    
    Abstract available

  69. TIAN F, Song W, Wang L, Zeng Q, et al
    NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study.
    Respir Res. 2021;22:321.
    PubMed    
    Abstract available

  70. XIONG J, Yu S, Liu R, Fang X, et al
    The Role of Conjunctival Microvasculation Combined with Echocardiography in Evaluating Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus.
    Dis Markers. 2021;2021:2135942.
    PubMed    
    Abstract available

  71. BRENT MB
    A review of the skeletal effects of exposure to high altitude and potential mechanisms for hypobaric hypoxia-induced bone loss.
    Bone. 2022;154:116258.
    PubMed    
    Abstract available

  72. SARZYNSKA K, Polanski J, Kopec G, Mroczek E, et al
    Cultural adaptation and validation of the Polish version of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) questionnaire.
    Kardiol Pol. 2021;79:1372-1374.
    PubMed    


  73. GALIE N, Gaine S, Channick R, Coghlan JG, et al
    Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension.
    Adv Ther. 2022;39:796-810.
    PubMed    
    Abstract available

  74. TARIQ S, Tervaert JWC, Osman M
    Diagnosis of pulmonary arterial hypertension preceding the confirmation of systemic sclerosis in a patient with Raynaud's phenomenon.
    Microvasc Res. 2022;139:104267.
    PubMed    


  75. KUMAR S, Frid MG, Zhang H, Li M, et al
    Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages.
    JCI Insight. 2021;6.
    PubMed    
    Abstract available

  76. ALFONSO F, Garcia-Guimaraes M, Alvarado T, Sanz-Ruiz R, et al
    Clinical implications of arterial hypertension in patients with spontaneous coronary artery dissection.
    Coron Artery Dis. 2022;33:75-80.
    PubMed    
    Abstract available

  77. GIERHARDT M, Pak O, Sydykov A, Kraut S, et al
    Genetic deletion of p66shc and/or cyclophilin D results in decreased pulmonary vascular tone.
    Cardiovasc Res. 2022;118:305-315.
    PubMed    
    Abstract available

  78. PENUMATSA KC, Singhal AA, Warburton RR, Bear MD, et al
    Vascular smooth muscle ROCK1 contributes to hypoxia-induced pulmonary hypertension development in mice.
    Biochem Biophys Res Commun. 2022;604:137-143.
    PubMed    
    Abstract available

  79. WALSH KF, Lui JK
    Post-tuberculosis pulmonary hypertension: a case of global disparity in health care.
    Lancet Glob Health. 2022;10:e476.
    PubMed    


  80. PUGLIESE NR, Mazzola M, Madonna R, Gargani L, et al
    Exercise-induced pulmonary hypertension in HFpEF and HFrEF: Different pathophysiologic mechanism behind similar functional impairment.
    Vascul Pharmacol. 2022 Mar 14:106978. doi: 10.1016/j.vph.2022.106978.
    PubMed    
    Abstract available

  81. LYSSENS A, Lekane M, Gommeren K, Merveille AC, et al
    Focused Cardiac Ultrasound to Detect Pre-capillary Pulmonary Hypertension.
    Front Vet Sci. 2022;9:830275.
    PubMed    
    Abstract available

  82. DING XH, Chai X, Zheng J, Chang H, et al
    Baseline Ratio of Soluble Fas/FasL Predicts Onset of Pulmonary Hypertension in Elder Patients Undergoing Maintenance Hemodialysis: A Prospective Cohort Study.
    Front Physiol. 2022;13:847172.
    PubMed    
    Abstract available

  83. SHIBAYAMA J, Tada H, Morita M, Yoshida S, et al
    A Case of Pulmonary Hypertension in a 67-Year-Old Woman with Thiamine Deficiency Following Partial Gastrectomy and Exacerbated by Diuretics.
    Am J Case Rep. 2022;23:e935308.
    PubMed    
    Abstract available

  84. ZENG QX, Yang T, Xi QY, Zhao ZH, et al
    Bilateral pulmonary artery stenosis with pulmonary hypertension due to Takayasu's arteritis, examined using quantitative flow ratio during revascularization.
    Eur Heart J Case Rep. 2021;6:ytab495.
    PubMed    


  85. KARPOV AA, Vaulina DD, Smirnov SS, Moiseeva OM, et al
    Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension.
    Heliyon. 2022;8:e09014.
    PubMed    
    Abstract available

  86. NEDER JA, Berton DC, O'Donnell DE
    Breathing too much! Ventilatory inefficiency and exertional dyspnea in pulmonary hypertension.
    J Bras Pneumol. 2022;48:e20220037.
    PubMed    


  87. BIKOU O, Tharakan S, Yamada K, Kariya T, et al
    Endo-bronchial aerosolized AAV1.SERCA2a gene therapy in a pulmonary hypertension pig model: addressing the lung delivery bottleneck.
    Hum Gene Ther. 2022 Mar 16. doi: 10.1089/hum.2021.
    PubMed    
    Abstract available

  88. BONNET D, Szezepanski I, Delacourt C, Malkezadeh-Milani S, et al
    Multifactorial pulmonary hypertension in infantile scimitar syndrome.
    Arch Cardiovasc Dis. 2022 Mar 4. pii: S1875-2136(22)00044.
    PubMed    
    Abstract available

  89. AURANGABADKAR GM, Lanjewar AV, Jadhav US, Ali SN, et al
    Evaluation of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.
    Cureus. 2022;14:e21828.
    PubMed    
    Abstract available

  90. AN J, Nam Y, Cho H, Chang J, et al
    Acute Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension: Clinical and Serial CT Pulmonary Angiographic Features.
    J Korean Med Sci. 2022;37:e76.
    PubMed    
    Abstract available

  91. WU XG, Shi YJ, Wang XH, Yu XW, et al
    Diagnostic value of computed tomography-based pulmonary artery to aorta ratio measurement in chronic obstructive pulmonary disease with pulmonary hypertension: A systematic review and meta-analysis.
    Clin Respir J. 2022 Mar 14. doi: 10.1111/crj.13485.
    PubMed    
    Abstract available

  92. SAKARIN S, Rungsipipat A, Surachetpong SD
    Expression of apoptotic proteins in the pulmonary artery of dogs with pulmonary hypertension secondary to degenerative mitral valve disease.
    Res Vet Sci. 2022;145:238-247.
    PubMed    
    Abstract available

  93. CHIU SN, Lu CW, Lin MT, Chen CA, et al
    Pulmonary Hypertension in Adult Congenital Heart Disease in Asia: A Distinctive Feature of Complex Congenital Heart Disease.
    J Am Heart Assoc. 2022 Mar 14:e022596. doi: 10.1161/JAHA.121.022596.
    PubMed    
    Abstract available

  94. HE W, Liu C, Liao J, Liu F, et al
    TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients.
    Front Med (Lausanne). 2022;8:774623.
    PubMed    
    Abstract available

  95. YAMAGATA Y, Ikeda S, Kojima S, Ueno Y, et al
    Right Ventricular Dyssynchrony in Patients With Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension.
    Circ J. 2022 Mar 12. doi: 10.1253/circj.CJ-21-0849.
    PubMed    
    Abstract available

  96. SINGH SP, Raju SN, Singh A
    In response to the article "Main pulmonary artery-to-descending aorta ratio in computed tomography: cut-off value to diagnose pulmonary hypertension in children". Pol J Radiol 2021; 86: e87-e125.
    Pol J Radiol. 2022;87:e125.
    PubMed    


  97. CHAI T, Qiu C, Xian Z, Lu Y, et al
    A narrative review of research advances in hypoxic pulmonary hypertension.
    Ann Transl Med. 2022;10:230.
    PubMed    
    Abstract available

  98. LEPSY N, Dering MR, Fuge J, Meltendorf T, et al
    Childhood Maltreatment, Mental Well-Being, and Healthy Lifestyle in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Front Psychiatry. 2022;13:821468.
    PubMed    
    Abstract available

  99. ZHANG RY, Liu J, Sun Y, Wang W, et al
    [Metabolic reprogramming in pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:313-317.
    PubMed    
    Abstract available

  100. CHEN YL, Zhang TT, Chen YQ, Wang J, et al
    [Progress on the pathogenesis of chronic thromboembolic pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:304-308.
    PubMed    
    Abstract available

  101. YANG L, Zhang L, Chen S, Li M, et al
    Efficacy of interatrial shunt devices: an opening window to acute pulmonary hypertensive crisis and chronic pulmonary arterial hypertension.
    J Thromb Thrombolysis. 2022 Mar 13. pii: 10.1007/s11239-022-02635.
    PubMed    
    Abstract available

  102. YI J, Wang X, Song K, Ren J, et al
    Integrated metabolomics and mechanism to reveal the protective effect of kaempferol on pulmonary arterial hypertension.
    J Pharm Biomed Anal. 2022;212:114662.
    PubMed    
    Abstract available

  103. MLECZKO M, Gerkowicz A, Krasowska D
    Chronic Inflammation as the Underlying Mechanism of the Development of Lung Diseases in Psoriasis: A Systematic Review.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  104. AJAM M, Drake M, Ran R, Mukundan S, et al
    Approach to echocardiography in ARDS patients in the prone position: A systematic review.
    Echocardiography. 2022;39:330-338.
    PubMed    
    Abstract available

  105. KASSIS-GEORGE H, Raina A
    Normal resting and exercise hemodynamics in pulmonary arterial hypertension: The roadmap to prostacyclin withdrawal?
    Int J Cardiol. 2022;350:109-110.
    PubMed    


  106. ZHANG W, Qi Y, Wu B
    MicroRNA-146-5p Promotes Pulmonary Artery Endothelial Cell Proliferation under Hypoxic Conditions through Regulating USP3.
    Dis Markers. 2021;2021:3668422.
    PubMed    
    Abstract available

  107. PAN Y, Sun Y, He L
    Predictive factors for concomitant pulmonary arterial hypertension at diagnosis of systemic lupus erythematosus in a Chinese population.
    Int J Rheum Dis. 2022;25:76-82.
    PubMed    
    Abstract available

  108. LI N, Zhu L, Zhu C, Zhou H, et al
    BMPR2 promoter methylation and its expression in valvular heart disease complicated with pulmonary artery hypertension.
    Aging (Albany NY). 2021;13:24580-24604.
    PubMed    
    Abstract available

  109. KACPRZAK A, Burakowska B, Kurzyna M, Fijalkowska A, et al
    Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension.
    Respir Res. 2021;22:293.
    PubMed    
    Abstract available

  110. DING Y, Tu P, Chen Y, Huang Y, et al
    CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro.
    Respir Res. 2021;22:291.
    PubMed    
    Abstract available

  111. XANTHOULI P, Theobald V, Benjamin N, Marra AM, et al
    Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension.
    Respir Res. 2021;22:288.
    PubMed    
    Abstract available

  112. BERTOLIZIO G, Engelhardt T, Veyckemans F
    Congenital interstitial lung diseases: What the anaesthesiologist needs to know.
    Paediatr Anaesth. 2021 Nov 5. doi: 10.1111/pan.14325.
    PubMed    
    Abstract available

  113. RAMPA DR, Murugesan P, Chao H, Feng H, et al
    Reversal of pulmonary arterial hypertension and neointimal formation by kinin B1 receptor blockade.
    Respir Res. 2021;22:281.
    PubMed    
    Abstract available

  114. UMEI M, Saito A, Soma K, Inaba T, et al
    Clinical Outcome of Closure of a Small Atrial Septal Defect in a Patient with Pulmonary Arterial Hypertension.
    Intern Med. 2022;61:851-855.
    PubMed    
    Abstract available

  115. LI P, Song J, Du H, Lu Y, et al
    MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-beta1/smad2/3 signaling.
    J Mol Cell Cardiol. 2021;161:9-22.
    PubMed    
    Abstract available

  116. MIGLANI M, Pasha Q, Gupta A, Priyadarshini A, et al
    Seeding drug discovery: Telomeric tankyrase as a pharmacological target for the pathophysiology of high-altitude hypoxia.
    Drug Discov Today. 2021;26:2774-2781.
    PubMed    
    Abstract available

  117. VLACHOU M, Fayed H, Dawson A, Reddecliffe S, et al
    Intravenous prostanoids in systemic sclerosis-associated pulmonary arterial hypertension: a single-centre experience.
    Rheumatology (Oxford). 2022;61:1106-1114.
    PubMed    
    Abstract available

  118. LAI J, Guo X, Zhao J, Wang H, et al
    Interventricular systolic asynchrony predicts prognosis in patients with systemic sclerosis-associated pulmonary arterial hypertension.
    Rheumatology (Oxford). 2022;61:983-991.
    PubMed    
    Abstract available

  119. LEE C, Hamlyn J, Porcelli J, Schmit A, et al
    Practical considerations in the management of inhaled prostacyclin therapy for pulmonary hypertension associated with interstitial lung disease (WHO group 3).
    Respir Med. 2022;196:106806.
    PubMed    
    Abstract available

  120. WU XH, Ma JL, Ding D, Ma YJ, et al
    Experimental animal models of pulmonary hypertension: Development and challenges.
    Animal Model Exp Med. 2022 Mar 25. doi: 10.1002/ame2.12220.
    PubMed    
    Abstract available

  121. BOXHAMMER E, Mirna M, Baz L, Bacher N, et al
    Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
    Life (Basel). 2022;12.
    PubMed    
    Abstract available

  122. JIANG R, Wang L, Zhao QH, Wu C, et al
    Echocardiography Nomogram for Predicting Survival among Chronic Lung Disease Patients with Severe Pulmonary Hypertension.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  123. RUARO B, Salton F, Baratella E, Confalonieri P, et al
    An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  124. SIEFKES H, Sunderji S, Vaughn J, Sankaran D, et al
    Factors to Consider to Study Preductal Oxygen Saturation Targets in Neonatal Pulmonary Hypertension.
    Children (Basel). 2022;9.
    PubMed    
    Abstract available

  125. KUROPATKINA T, Pavlova O, Gulyaev M, Pirogov Y, et al
    Sex-Dependent Protective Effect of Combined Application of Solubilized Ubiquinol and Selenium on Monocrotaline-Induced Pulmonary Hypertension in Wistar Rats.
    Antioxidants (Basel). 2022;11.
    PubMed    
    Abstract available

  126. REYES-GARCIA J, Carbajal-Garcia A, Di Mise A, Zheng YM, et al
    Important Functions and Molecular Mechanisms of Mitochondrial Redox Signaling in Pulmonary Hypertension.
    Antioxidants (Basel). 2022;11.
    PubMed    
    Abstract available

  127. DALEN ML, Vigerust NF, Hammarstrom C, Holmstrom H, et al
    Neonatal interstitial lung disease in a girl with Jacobsen syndrome: a case report.
    J Med Case Rep. 2022;16:117.
    PubMed    
    Abstract available

  128. LE PENNEC R, Tromeur C, Orione C, Robin P, et al
    Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
    Front Med (Lausanne). 2022;9:851935.
    PubMed    
    Abstract available

  129. CASTILLO-GALAN S, Arenas GA, Iturriaga R
    CONTRIBUTION OF STIM-ACTIVATED TRPC-ORAI CHANNELS IN PULMONARY HYPERTENSION INDUCED BY CHRONIC SUSTAINED AND INTERMITTENT HYPOXIA.
    Curr Vasc Pharmacol. 2022 Mar 21. pii: CVP-EPUB-121749.
    PubMed    
    Abstract available

  130. YOSHIDA T, Nagaoka T, Nagata Y, Suzuki Y, et al
    Periostin-related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF-2 signalling.
    Respirology. 2022 Mar 22. doi: 10.1111/resp.14249.
    PubMed    
    Abstract available

  131. GUPTA R, Baughman RP, Nathan SD, Wells AU, et al
    The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
    Respir Med. 2022;196:106801.
    PubMed    
    Abstract available

  132. MCNAMARA PJ, Giesinger RE, Lakshminrusimha S
    Dopamine and Neonatal Pulmonary Hypertension - Pressing Need for a Better Pressor?
    J Pediatr. 2022 Mar 18. pii: S0022-3476(22)00207.
    PubMed    


  133. BALDI BG, Souza R
    Pulmonary Hypertension in Interstitial Lung Disease.
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00092.
    PubMed    


  134. BLANCO I, Torres-Castro R, Barbera JA
    Exercise tolerance in pulmonary hypertension.
    Arch Bronconeumol. 2021 Dec 6. pii: S0300-2896(21)00388.
    PubMed    


  135. JOHNSON SW, Gillmeyer KR, Bolton RE, McCullough MB, et al
    Variable Monitoring of Veterans with Group 3 Pulmonary Hypertension Treated with Off-Label Pulmonary Vasodilator Therapy.
    Ann Am Thorac Soc. 2022 Mar 21. doi: 10.1513/AnnalsATS.202110-1168.
    PubMed    


  136. SANG P, Kucherenko MM, Yao J, Li Q, et al
    A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
    J Vis Exp. 2022;.
    PubMed    
    Abstract available

  137. GARCIA-GONZALEZ MA, Vallejo-Ruiz V, Atonal-Flores F, Flores-Hernandez J, et al
    Sildenafil prevents right ventricular hypertrophy and improves heart rate variability in rats with pulmonary hypertension secondary to experimental diabetes.
    Clin Exp Hypertens. 2022 Mar 20:1-11. doi: 10.1080/10641963.2022.2050743.
    PubMed    
    Abstract available

  138. WANG S, Yan Y, Xu WJ, Gong SG, et al
    The Role of Glutamine and Glutaminase in Pulmonary Hypertension.
    Front Cardiovasc Med. 2022;9:838657.
    PubMed    
    Abstract available

  139. DERING MR, Lepsy N, Fuge J, Meltendorf T, et al
    Prevalence of Mental Disorders in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Front Psychiatry. 2022;13:821466.
    PubMed    
    Abstract available

  140. GOMES MT, Bai Y, Potje SR, Zhang L, et al
    Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  141. CHEN J, Tian Z, Zhang H, Shi L, et al
    Risks of postoperative respiratory failure in elderly patients after hip surgery: a retrospective study.
    J Orthop Surg Res. 2022;17:140.
    PubMed    
    Abstract available

  142. WANG J, Uddin MN, Li Q, Aierken A, et al
    Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model.
    Oxid Med Cell Longev. 2022;2022:8401924.
    PubMed    
    Abstract available

  143. KRAUTER C, Reiter U, Kovacs G, Reiter C, et al
    Automated vortical blood flow-based estimation of mean pulmonary arterial pressure from 4D flow MRI.
    Magn Reson Imaging. 2022 Feb 18. pii: S0730-725X(22)00032.
    PubMed    
    Abstract available

  144. HEERDT PM, Singh I, Elassal A, Kheyfets V, et al
    Pressure-based estimation of right ventricular ejection fraction.
    ESC Heart Fail. 2022;9:1436-1443.
    PubMed    
    Abstract available

  145. BAUMANN P, Greco F, Wiegert S, Wellmann S, et al
    Macitentan attenuates cardiovascular remodelling in infant rats with chronic lung disease.
    J Transl Med. 2022;20:77.
    PubMed    
    Abstract available

  146. ALVAREZ P, Briasoulis A
    Innovations and challenges across the heart failure spectrum.
    Rev Cardiovasc Med. 2022;23:35.
    PubMed    


  147. PANT S, Sizarov A, Knepper A, Gossard G, et al
    Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study.
    Biomech Model Mechanobiol. 2022;21:471-511.
    PubMed    
    Abstract available

  148. WATANABE T, Ishikawa M, Abe K, Ishikawa T, et al
    Increased Lung Uric Acid Deteriorates Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2021;10:e022712.
    PubMed    
    Abstract available

  149. H CANBEYLI F, Atasayan V, Tokgoz S, Tunaoglu FS, et al
    Health-related quality of life and parental depression in children with pulmonary arterial hypertension.
    Pediatr Pulmonol. 2022;57:544-550.
    PubMed    
    Abstract available

  150. ZHANG Y, Zervopoulos SD, Boukouris AE, Lorenzana-Carrillo MA, et al
    SNPs for Genes Encoding the Mitochondrial Proteins Sirtuin3 and Uncoupling Protein 2 Are Associated With Disease Severity, Type 2 Diabetes, and Outcomes in Patients With Pulmonary Arterial Hypertension and This Is Recapitulated in a New Mouse Model La
    J Am Heart Assoc. 2021;10:e020451.
    PubMed    
    Abstract available

  151. MIRTAJADDINI M, Naderi N, Chenaghlou M, Taghavi S, et al
    The prediction of right atrial pressure using electrocardiogram: a novel approach.
    ESC Heart Fail. 2021;8:5040-5044.
    PubMed    
    Abstract available

  152. ROSENKRANZ S, Feldman J, McLaughlin VV, Rischard F, et al
    Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet Respir Med. 2022;10:35-46.
    PubMed    
    Abstract available

  153. JANKOWICH M, Maron BA, Choudhary G
    Mildly elevated pulmonary artery systolic pressure on echocardiography: bridging the gap in current guidelines.
    Lancet Respir Med. 2021;9:1185-1191.
    PubMed    
    Abstract available

  154. LIU Y, Hu R, Zhu J, Nie X, et al
    The lncRNA PAHRF functions as a competing endogenous RNA to regulate MST1 expression by sponging miR-23a-3p in pulmonary arterial hypertension.
    Vascul Pharmacol. 2021;139:106886.
    PubMed    
    Abstract available

  155. HODGSON J, Ruiz-Llorente L, McDonald J, Quarrell O, et al
    Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in children.
    Mol Genet Genomic Med. 2021;9:e1685.
    PubMed    
    Abstract available

  156. GLOWACKI K, Grabka M, Myszor J, Maciejewski T, et al
    Pregnant 30-year-old with idiopathic pulmonary arterial hypertension.
    Ginekol Pol. 2021;92:252-253.
    PubMed    


  157. MAARMAN GJ
    Reviewing the suitability of mitochondrial transplantation as therapeutic approach for pulmonary hypertension in the era of personalised medicine.
    Am J Physiol Lung Cell Mol Physiol. 2022 Mar 23. doi: 10.1152/ajplung.00484.2021
    PubMed    
    Abstract available

  158. CHIN CW, Bichell DP
    Misclassification of pulmonary hypertension in partial anomalous pulmonary venous return.
    Ann Thorac Surg. 2022 Feb 26. pii: S0003-4975(22)00281.
    PubMed    
    Abstract available

  159. MARRA AM, Sherman AE, Salzano A, Guazzi M, et al
    Right Heart-Pulmonary Circulation Unit Involvement in Left-sided Heart Failure: Diagnostic, Prognostic and Therapeutic Implications. From the Forgotten Chamber to the Chamber of Secrets.
    Chest. 2021 Sep 27. pii: S0012-3692(21)04062-9. doi: 10.1016/j.chest.2021.
    PubMed    
    Abstract available

  160. GENTY T, Wirth C, Humbert M, Fadel E, et al
    Pulmonary Endarterectomy in Patients With Myeloproliferative Neoplasms.
    Chest. 2022;161:552-556.
    PubMed    


  161. CULLEY MK, Chan SY
    Endothelial Senescence: A New Age in Pulmonary Hypertension.
    Circ Res. 2022;130:928-941.
    PubMed    
    Abstract available

  162. LECHUGA-VIECO AV, Latorre-Pellicer A, Calvo E, Torroja C, et al
    Heteroplasmy of Wild Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
    Circulation. 2022 Mar 3. doi: 10.1161/CIRCULATIONAHA.121.056286.
    PubMed    
    Abstract available

  163. XUE L, Yang YC, Zhao Q, Zhao ZH, et al
    The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23803.
    PubMed    
    Abstract available

  164. HANSMANN G, Diekmann F, Chouvarine P, Ius F, et al
    Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH.
    J Heart Lung Transplant. 2021 Oct 29. pii: S1053-2498(21)02568.
    PubMed    
    Abstract available

  165. HUMBERT M, Simonneau G, Pittrow D, Delcroix M, et al
    Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2022 Feb 11. pii: S1053-2498(22)01804.
    PubMed    
    Abstract available

  166. JOSE A, Shah SA, Anwar N, Jones CR, et al
    Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension.
    Liver Transpl. 2021;27:1811-1823.
    PubMed    
    Abstract available

  167. VALETTE K, Bermudez J, Habert P, Puech B, et al
    [Computed tomography lung density and small vessel quantification in pulmonary hypertension associated with progressive fibrosing interstitial lung disease (PF-ILD)].
    Rev Mal Respir. 2022 Feb 24. pii: S0761-8425(21)00414.
    PubMed    
    Abstract available

  168. VALENTIN S, Maurac A, Mandry D, Selton-Suty C, et al
    [The role of cardiac magnetic resonance imaging in pulmonary arterial hypertension and chronic thrombo-embolic pulmonary hypertension].
    Rev Mal Respir. 2022 Mar 16. pii: S0761-8425(22)00132.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;